NASDAQ:QCLS • US62856X3008
The current stock price of QCLS is 3.7 USD. Today QCLS is up by 3.06%. In the past month the price decreased by -5.37%.
ChartMill assigns a technical rating of 1 / 10 to QCLS.
ChartMill assigns a fundamental rating of 2 / 10 to QCLS. QCLS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months QCLS reported a non-GAAP Earnings per Share(EPS) of -165.47. The EPS increased by 87.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -31.05% | ||
| ROE | -54.23% | ||
| Debt/Equity | 0 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 29.9 | 948.755B | ||
| JNJ | JOHNSON & JOHNSON | 21.05 | 591.001B | ||
| MRK | MERCK & CO. INC. | 22.23 | 298.537B | ||
| PFE | PFIZER INC | 8.86 | 151.354B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 10.24 | 126.888B | ||
| ZTS | ZOETIS INC | 18.34 | 55.509B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 9.14 | 27.378B | ||
| VTRS | VIATRIS INC | 5.86 | 16.937B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.23 | 12.151B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.393B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.67B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 4.517B | ||
| GPCR | STRUCTURE THERAPEUTICS INC | N/A | 4.459B |
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2008-07-24. The Company, through a licensing agreement with LightSolver, holds rights to the use of quantum-inspired laser-based processing units (LPUs) that solve compute-intensive combinatorial and physical problems at the speed of light. The firm bridges a disruptive computing paradigm for high-speed photonic computing with cryptocurrency infrastructure development at scale, enabling performance and sustainability for blockchain applications. Lightsolver’s architecture is designed to improve security for blockchain operations for the cryptocurrency industry.
Q/C TECHNOLOGIES INC
1185 Avenue Of The Americas, Suite 249
New York City NEW YORK US
Employees: 2
Phone: 13026587581
Q/C Technologies, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2008-07-24. The Company, through a licensing agreement with LightSolver, holds rights to the use of quantum-inspired laser-based processing units (LPUs) that solve compute-intensive combinatorial and physical problems at the speed of light. The firm bridges a disruptive computing paradigm for high-speed photonic computing with cryptocurrency infrastructure development at scale, enabling performance and sustainability for blockchain applications. Lightsolver’s architecture is designed to improve security for blockchain operations for the cryptocurrency industry.
The current stock price of QCLS is 3.7 USD. The price increased by 3.06% in the last trading session.
QCLS does not pay a dividend.
QCLS has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
You can find the ownership structure of Q/C TECHNOLOGIES INC (QCLS) on the Ownership tab.
The outstanding short interest for Q/C TECHNOLOGIES INC (QCLS) is 25.21% of its float.